Interestingly, depleting CD4+ T cells enhanced the anti-tumor efficacy of FL/GM-DCs, possibly due to the reduction in Tregs, thereby decreasing immunosuppression and potentiating the therapeutic effect against cancer (Figures 6f, g). Here, CD4 is linked to cancer.